skip to main content
Back to all blog posts

Posted in: Intellectual Property | Upcoming Events

Feb 7, 2017

Complimentary Webinar - Canadian Pharma Update: Patent Law

Join us for a complimentary webinar on Thursday, February 9 from 9 - 10 a.m. regarding upcoming changes to the Canadian patent regime. The top 10 Canadian patent developments of concern to pharmaceutical companies will be discussed, including:

  • Supreme Court of Canada considers utility requirements - defining the "Promise"
  • Validity of biologic patents
  • Upcoming legislative implementation of CETA, including two-year patent extensions
  • Patented Medicines Prices Review Board - review of orphan drug pricing

Click here to register

Speakers

Paula Bremner is a lawyer and member of  Aird & Berlis LLP's Litigation Group and Intellectual Property Group. She is a registered Canadian patent and trademark agent. Paula specializes in pharmaceutical patent litigation, particularly in the context of the Patented Medicines (Notice of Compliance) Regulations.

 

 

Kimberly McManus, (Ph.D.) is a registered patent agent and member of Aird & McBurney LP. She specializes in patent protection and enforcement issues for the pharmaceutical and chemical industries.

 

 

CPD for Lawyers: 1 Substantive Hour

 

Related Blogs

Posted in: Intellectual Property

Insights TheSpotlight
Quebec Court Denies Exclusive Use Of Geographic Location in Car Dealership’s Name By Stan Fedun and Ken Clark Jun 18, 2018 In the recent Superior Court of Quebec decision, 7531877 Canada ltée (Buckingham Chrysler, Jeep, Dodge) c 9531025 Canada Inc. (Buckingham Chevrolet Buick GMC), dated May 17, 2018, the plaintiff alleged that the defendant engaged in false advertising (name appropriation) by using “Buckingham” in i...

Posted in: Intellectual Property

Insights TheSpotlight
Certificates of Supplementary Protection for Canadian Pharmaceutical Patents By Kitt Sinden, M.Sc. May 15, 2018 Patents granted in Canada have typically carried a 20-year term of protection from the date of filing, regardless of the time taken to be examined and granted by the Patent Office or for the underlying products to be approved by regulatory agencies. However, since September 2017, as part of conce...

Posted in: Intellectual Property

Insights TheSpotlight
U.S. Court of Appeals Finds That the Lines Remain Blurred By Ken Clark and Tyler Brent Apr 20, 2018 In 2013, Pharrell Williams’ and Robin Thicke’s smash hit “Blurred Lines” swept the globe as the number one single for the year. Shortly after reaching number one, Pharrell and Thicke were sued for copyright infringement for infringing Marvin Gaye’s “Got to Give it Up.” At trial, a jury found Phar...